The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Advisers, some employees and some board members are scoring payouts ranging from $75,000 to $53 million.

Polaris Partners has launched a new Cambridge biotech that, if successful, could prevent Type 1 diabetes from occurring or ...

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

The biotech sector has long offered investors high-risk, high-reward stocks. While large players are making headlines, the ...

In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...

Nautilus will host a conference call to discuss the third quarter 2025 financial results, business developments and outlook before market open on Tuesday, October 28, 2025, at 5:30 AM Pacific Time / 8 ...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) shares have shown interesting movement recently, supported by a mix of strong revenue growth and improved net income figures. Investors are watching ...

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage ... This press release may contain forward-looking statements within the meaning of Section 27A of the ...

Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...

Study met primary and secondary endpointsParidiprubart demonstrated a relative reduction in the risk of death of 25%Treatment provided patients with clinically meaningful improvement in survival and ...